Valuation: Procyon Corporation

Market Cap 1.55M 1.35M 1.27M 1.15M 2.16M 148M 2.17M 15.2M 5.87M 75.42M 5.81M 5.68M 243M P/E 2023
-25x
P/E 2024 -5.75x
Enterprise Value 1.06M 927K 875K 795K 1.49M 102M 1.5M 10.46M 4.04M 51.91M 4M 3.91M 167M EV / Sales 2023
0.34x
EV / Sales 2024 0.28x
Free-Float
35.53%
Yield 2023 *
-
Yield 2024 -
1 day+48.94%
1 week+12.00%
Current month+12.00%
1 month+12.00%
3 months+39.30%
6 months+48.94%
Current year+131.40%
1 week 0.26
Extreme 0.26
0.28
1 month 0.25
Extreme 0.25
0.28
Current year 0.12
Extreme 0.12
0.28
1 year 0.1
Extreme 0.1
0.28
3 years 0
Extreme 1.0E-6
0.34
5 years 0
Extreme 1.0E-6
0.64
10 years 0
Extreme 1.0E-6
1
Manager TitleAgeSince
Chief Executive Officer 49 09/01/2018
Chief Executive Officer 56 22/09/2005
Director TitleAgeSince
Director/Board Member 49 01/01/2006
Director/Board Member 56 01/12/2006
Chairman 79 01/09/2005
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/24 A Other

Director

12,848 0.1585%
7/31/24 A Other

Director

7,200 0.0888%
7/31/24 A Other

Director

5,600 0.0691%
Change 5-day change 1-year change 3-year change Capi.($)
+48.94%+12.00%+174.51%+1.73% 2.13M
+0.04%+3.34%+51.12%+101.82% 1,028B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 466B
-1.22%+3.66%+36.44%+38.32% 346B
-0.79%+2.73%+19.03%+25.08% 266B
+0.58%+6.76%+11.13%+16.52% 259B
+1.55%+2.20%+39.81%+46.55% 208B
+0.79%+1.84%-28.27%-56.71% 191B
-0.52%+4.45%+32.12%+98.51% 186B
Average +4.93%+2.93%+40.98%+40.95% 360.17B
Weighted average by Cap. -0.04%+3.09%+35.15%+61.76%

Financials

2023 2024
Net sales 4.69M 4.08M 3.85M 3.5M 6.56M 449M 6.59M 46.06M 17.79M 229M 17.6M 17.21M 735M 4.98M 4.34M 4.1M 3.72M 6.97M 478M 7M 48.99M 18.92M 243M 18.72M 18.31M 782M
Net income -50.24K -43.74K -41.29K -37.52K -70.28K -4.82M -70.6K -494K -191K -2.45M -189K -185K -7.88M -341K -297K -280K -255K -477K -32.71M -479K -3.35M -1.3M -16.63M -1.28M -1.25M -53.51M
Net Debt -427K -372K -351K -319K -598K -40.99M -601K -4.2M -1.62M -20.84M -1.61M -1.57M -67.05M -482K -420K -396K -360K -674K -46.22M -677K -4.74M -1.83M -23.51M -1.81M -1.77M -75.62M
Logo Procyon Corporation
Procyon Corporation operates through its subsidiary AMERX Health Care Corporation (AMERX). AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. It provides skin and wound care products through its proprietary brands, AMERIGEL Advanced Skin and Wound Care, HELIX3 Bioactive Collagen, and EXTREMIT-EASE compresson Garment. Its AMERIGEL products are made with Oakin, that promote healing in wounds and problematic skin conditions while fighting infection, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its kits and dressings products include AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Thin Hydrocolloid Dressings, and AMERX Wound Care Kits.
Employees
20
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PCYN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!